NPI: 1386727923 · SOUDERTON, PA 18964 · Pediatrics Physician · NPI assigned 10/24/2006
Authorized official STONE, FABIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | STONE, FABIAN (VP REVENUE CYCLE) |
| Parent Organization | CHILDREN'S HOSPITAL OF PHILADELPHIA |
| NPI Enumeration Date | 10/24/2006 |
Other providers sharing the same authorized official: STONE, FABIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 754 | $31K |
| 2019 | 955 | $31K |
| 2020 | 3,021 | $48K |
| 2021 | 7,122 | $169K |
| 2022 | 8,481 | $354K |
| 2023 | 10,768 | $485K |
| 2024 | 9,835 | $488K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,304 | 13,435 | $766K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,258 | 4,036 | $363K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,739 | 1,687 | $78K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,498 | 1,479 | $61K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 917 | 814 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 193 | 189 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 453 | 442 | $31K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 442 | 419 | $24K |
| 92551 | 1,841 | 1,793 | $24K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 469 | 461 | $23K |
| 99499 | 1,157 | 1,082 | $22K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,469 | 1,419 | $20K |
| 90688 | 1,749 | 1,743 | $17K | |
| 90686 | 1,462 | 1,456 | $15K | |
| 0072A | 198 | 194 | $11K | |
| 96127 | 1,340 | 1,328 | $11K | |
| 0071A | 143 | 141 | $10K | |
| 90656 | 592 | 590 | $7K | |
| 90648 | 885 | 881 | $7K | |
| 90670 | 831 | 827 | $6K | |
| 90461 | 79 | 65 | $6K | |
| 90651 | 430 | 429 | $5K | |
| 85018 | 973 | 939 | $5K | |
| 90723 | 638 | 637 | $5K | |
| 90633 | 497 | 494 | $3K | |
| 3008F | 319 | 319 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 187 | 176 | $3K |
| 90681 | 340 | 339 | $3K | |
| 99173 | 244 | 222 | $2K | |
| 90734 | 199 | 199 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 105 | 105 | $2K |
| 99177 | 215 | 213 | $1K | |
| 90707 | 92 | 90 | $883.20 | |
| 99188 | 26 | 26 | $828.99 | |
| 90716 | 77 | 77 | $742.40 | |
| 0004A | 13 | 12 | $738.71 | |
| 96161 | 103 | 103 | $656.18 | |
| 90700 | 86 | 86 | $646.17 | |
| 90715 | 52 | 52 | $627.20 | |
| 90671 | 42 | 42 | $502.40 | |
| 90710 | 106 | 106 | $422.40 | |
| 90620 | 26 | 26 | $332.80 | |
| 90696 | 85 | 85 | $278.74 | |
| 90687 | 14 | 14 | $209.68 | |
| 99000 | 48 | 47 | $137.83 |